GI DYNAMICS, INC - Announcements

Currently unlisted. Add to my watchlist

GI Dynamics, Inc. is a medical device company. The Company designs and applies device and... GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

GID	Removal from Official List		22/07/20	85.79KB	Share
GID	Suspension from Official Quotation	PRICE SENSITIVE	21/07/20	86.41KB	Share
GID	US$10 Million Financing and Restructuring Board of Directors	PRICE SENSITIVE	20/07/20	191.41KB	Share
GID	Completion of Tranche 1 Allotment	PRICE SENSITIVE	20/07/20	349.25KB	Share
GID	Further Delisting Update	PRICE SENSITIVE	15/07/20	156.83KB	Share
GID	Proposed issue of Securities - GID	PRICE SENSITIVE	15/07/20	24.89KB	Share
GID	Conversion of June 2017 Convertible Note	PRICE SENSITIVE	15/07/20	139.71KB	Share
GID	Trading Halt	PRICE SENSITIVE	14/07/20	301.97KB	Share
GID	Further Extension of 2017 Note and Financing Update	PRICE SENSITIVE	01/07/20	149.81KB	Share
GID	Stockholders Approve Delisting from the Official List	PRICE SENSITIVE	22/06/20	282.21KB	Share
GID	Placement of $750,000 Unsecured Convertible Promissory Note	PRICE SENSITIVE	19/06/20	164.38KB	Share
GID	Pause in Trading	PRICE SENSITIVE	19/06/20	115.57KB	Share
GID	Further Extension of Maturity Date of June 2017 Note	PRICE SENSITIVE	17/06/20	131.32KB	Share
GID	Trading Halt	PRICE SENSITIVE	15/06/20	171.89KB	Share
GID	Pause in Trading	PRICE SENSITIVE	15/06/20	115.52KB	Share
GID	Further Postponement of Special Meeting of Stockholders		15/06/20	160.94KB	Share
GID	Postponement of Special Meeting of Stockholders	PRICE SENSITIVE	05/06/20	162.39KB	Share
GID	Proposed Delisting from the Official List of ASX	PRICE SENSITIVE	27/05/20	552.98KB	Share
GID	Trading Halt	PRICE SENSITIVE	26/05/20	171.87KB	Share
GID	Further Extension of Maturity Date of June 2017 Note		18/05/20	130KB	Share
GID	Corporate Presentation Update		15/05/20	123.96KB	Share
GID	GID Receives Loan under US Paycheck Protection Program		15/05/20	150.9KB	Share
GID	Proposed Delisting from the Official List of ASX	PRICE SENSITIVE	11/05/20	231.7KB	Share
GID	Pause in Trading	PRICE SENSITIVE	11/05/20	115.3KB	Share
GID	Form 10-Q Filed with the SEC	PRICE SENSITIVE	07/05/20	485.1KB	Share
GID	Extension of Maturity Date of 2017 Note & Operational Update	PRICE SENSITIVE	04/05/20	147.55KB	Share
GID	Additional Information - Appendix 4C	PRICE SENSITIVE	04/05/20	322.82KB	Share
GID	Quarterly Activities Report - Q1 2020	PRICE SENSITIVE	01/05/20	133.53KB	Share
GID	GID Files Amendment to the Annual Report on SEC Form 10-K	PRICE SENSITIVE	30/04/20	126.54KB	Share
GID	Appendix 4C - Quarter Ended 31 March 2020	PRICE SENSITIVE	28/04/20	234.64KB	Share
GID	Extension of the Maturity Date of US $5M Convertible Note		01/04/20	136.57KB	Share
GID	Appendix 3Z		01/04/20	180.5KB	Share
GID	GI Dynamics Announces Change to Board of Directors		30/03/20	126.26KB	Share
GID	Appendix 4G - Annual Report		30/03/20	14.01MB	Share
GID	Notice of Special Meeting & Engagement of Financial Advisor		23/03/20	8.23MB	Share
GID	Appendix 3X		02/03/20	138.15KB	Share
GID	Appointment of Director		02/03/20	131.96KB	Share
GID	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	28/02/20	703.91KB	Share
GID	Change in substantial holding		03/02/20	232.7KB	Share
GID	1st Patient Enrolled in US STEP-1 EndoBarrier Clinical Trial	PRICE SENSITIVE	28/01/20	132.02KB	Share
GID	Change in substantial holding		28/01/20	272.67KB	Share
GID	Appendix 4C - Quarter Ended 31 December 2019	PRICE SENSITIVE	24/01/20	312.34KB	Share
GID	EndoBarrier Study Shows Improvement in Cardiovascular Risk	PRICE SENSITIVE	15/01/20	270.73KB	Share
GID	Confirmation of Funding of 2019 Note, Warrant Issuance & 3B		14/01/20	440.78KB	Share
GID	Results of Adjourned Special Meeting		20/12/19	282.61KB	Share
GID	Appendix 3Y		19/12/19	205.69KB	Share
GID	Appendix 3Y		19/12/19	226.11KB	Share
GID	Appendix 3Y		19/12/19	225.72KB	Share
GID	Appendix 3Y		19/12/19	205.85KB	Share
GID	Appendix 3B Following Stockholder Approvals		17/12/19	648.98KB	Share
GID	Results of Special Meeting	PRICE SENSITIVE	17/12/19	231.13KB	Share
GID	GID Announces Details of Special Meeting for Stockholders		12/12/19	127.56KB	Share
GID	Corporate Presentation		11/12/19	2.17MB	Share
GID	Note Funding Update & US Filings		09/12/19	406.73KB	Share
GID	Appointment of Auditor		09/12/19	294.74KB	Share
GID	GID Announces Extension of Note Funding Date	PRICE SENSITIVE	06/12/19	55.81KB	Share
GID	Details of Special Meeting and Confirmation of Note Funding		02/12/19	311.95KB	Share
GID	Appointment of an Observer to the Board of Directors		20/11/19	126.31KB	Share
GID	Exercise of Tranche 4 Warrants and Appendix 3B		18/11/19	409.4KB	Share
GID	Form 10-Q filed with SEC - Q3 2019	PRICE SENSITIVE	11/11/19	654.25KB	Share
GID	Change in substantial holding		11/11/19	182.34KB	Share
GID	Change in substantial holding		08/11/19	227.37KB	Share
GID	Exercise of Tranche 3 Warrants and Appendix 3B		04/11/19	790.28KB	Share
GID	Appendix 4C - Quarter Ended 30 September 2019	PRICE SENSITIVE	30/10/19	229.82KB	Share
GID	Change in substantial holding		07/10/19	259.5KB	Share
GID	Exercise of Tranche 2 Warrants by Crystal Amber and 3B	PRICE SENSITIVE	04/10/19	340.02KB	Share
GID	Variation of CEO Employment Terms and Issue of Options	PRICE SENSITIVE	20/09/19	590.6KB	Share
GID	Worldwide EndoBarrier Registry Data Presented at EASD 2019		20/09/19	186.84KB	Share
GID	Change in substantial holding		05/09/19	295.89KB	Share
GID	Change in substantial holding		29/08/19	703.63KB	Share
GID	Close of Tranche 1 Warrants Exercise and Appendix 3B		26/08/19	366.49KB	Share
GID	Change in substantial holding		26/08/19	274.11KB	Share
GID	GID Announces up to Approx.US$10M Financing w/ Crystal Amber	PRICE SENSITIVE	22/08/19	495.11KB	Share
GID	Half Yearly Report and Accounts	PRICE SENSITIVE	20/08/19	1MB	Share
GID	Surgical Specialists of Louisiana Contracted for STEP-1		31/07/19	113.36KB	Share
GID	Appendix 4C - Quarter Ended 30 June 2019	PRICE SENSITIVE	31/07/19	113.33KB	Share
GID	GID Confirms Thomas Jefferson Contracted for STEP-1		23/07/19	114.8KB	Share
GID	Lead Clinical Study Site for US Pivotal Trial of EndoBarrier	PRICE SENSITIVE	11/07/19	115.89KB	Share
GID	Change in substantial holding		08/07/19	260.52KB	Share
GID	Conversion of convertible notes by Crystal Amber		02/07/19	330.38KB	Share
GID	Issue of Warrants and Conversion of Convertible Notes		01/07/19	363.2KB	Share
GID	Results of 2019 Annual Meeting of Stockholders		01/07/19	175.49KB	Share
GID	Extension of Maturity Date of US $5M Convertible Note	PRICE SENSITIVE	01/07/19	132.67KB	Share
GID	GID Announces Access to 2019 Annual Meeting of Stockholders		25/06/19	135.39KB	Share
GID	Final Proxy Statement & Notice of 2019 Annual Meeting		21/06/19	1.08MB	Share
GID	2019 Annual Meeting of Stockholders - Further Update		18/06/19	56.01KB	Share
GID	New SAB Member to Focus on Treatment of Liver Disease		18/06/19	116.73KB	Share
GID	EndoBarrier End-OSA Shows Significant Improvements Sustained	PRICE SENSITIVE	14/06/19	165.29KB	Share
GID	Change in substantial holding		13/06/19	261.87KB	Share
GID	GID Confirms First 2 Clinical Study Sites Contracted	PRICE SENSITIVE	13/06/19	117.05KB	Share
GID	EndoBarrier Data to be Presented at ADA 2019		06/06/19	142.77KB	Share
GID	GI Dynamics 2019 Annual Meeting of Stockholders - Update	PRICE SENSITIVE	04/06/19	72.67KB	Share
GID	Q1 2019 Form 10-Q/A	PRICE SENSITIVE	20/05/19	375.92KB	Share
GID	Q1 2019 Form 10-Q and 12b-25	PRICE SENSITIVE	17/05/19	1.17MB	Share
GID	$3M Convertible Note & Warrant Financing from Crystal Amber	PRICE SENSITIVE	09/05/19	150.41KB	Share
GID	Extension of Maturity Date of US $5M Convertible Note	PRICE SENSITIVE	01/05/19	120.53KB	Share
GID	Appendix 4C - Quarter Ended 31 March 2019	PRICE SENSITIVE	30/04/19	268.12KB	Share
GID	GI Dynamics Announces New Scientific Advisory Board Member		09/04/19	117.14KB	Share
GID	EndoBarrier Data to be Presented at 4th WCITD		04/04/19	146.16KB	Share
GID	New SAB Member to Advance Focus on Chronic Kidney Disease		02/04/19	115.21KB	Share

GID Removal from Official List
22/07/20		85.79KB	Share
GID Suspension from Official Quotation
21/07/20	PRICE SENSITIVE	86.41KB	Share
GID US$10 Million Financing and Restructuring Board of Directors
20/07/20	PRICE SENSITIVE	191.41KB	Share
GID Completion of Tranche 1 Allotment
20/07/20	PRICE SENSITIVE	349.25KB	Share
GID Further Delisting Update
15/07/20	PRICE SENSITIVE	156.83KB	Share
GID Proposed issue of Securities - GID
15/07/20	PRICE SENSITIVE	24.89KB	Share
GID Conversion of June 2017 Convertible Note
15/07/20	PRICE SENSITIVE	139.71KB	Share
GID Trading Halt
14/07/20	PRICE SENSITIVE	301.97KB	Share
GID Further Extension of 2017 Note and Financing Update
01/07/20	PRICE SENSITIVE	149.81KB	Share
GID Stockholders Approve Delisting from the Official List
22/06/20	PRICE SENSITIVE	282.21KB	Share
GID Placement of $750,000 Unsecured Convertible Promissory Note
19/06/20	PRICE SENSITIVE	164.38KB	Share
GID Pause in Trading
19/06/20	PRICE SENSITIVE	115.57KB	Share
GID Further Extension of Maturity Date of June 2017 Note
17/06/20	PRICE SENSITIVE	131.32KB	Share
GID Trading Halt
15/06/20	PRICE SENSITIVE	171.89KB	Share
GID Pause in Trading
15/06/20	PRICE SENSITIVE	115.52KB	Share
GID Further Postponement of Special Meeting of Stockholders
15/06/20		160.94KB	Share
GID Postponement of Special Meeting of Stockholders
05/06/20	PRICE SENSITIVE	162.39KB	Share
GID Proposed Delisting from the Official List of ASX
27/05/20	PRICE SENSITIVE	552.98KB	Share
GID Trading Halt
26/05/20	PRICE SENSITIVE	171.87KB	Share
GID Further Extension of Maturity Date of June 2017 Note
18/05/20		130KB	Share
GID Corporate Presentation Update
15/05/20		123.96KB	Share
GID GID Receives Loan under US Paycheck Protection Program
15/05/20		150.9KB	Share
GID Proposed Delisting from the Official List of ASX
11/05/20	PRICE SENSITIVE	231.7KB	Share
GID Pause in Trading
11/05/20	PRICE SENSITIVE	115.3KB	Share
GID Form 10-Q Filed with the SEC
07/05/20	PRICE SENSITIVE	485.1KB	Share
GID Extension of Maturity Date of 2017 Note & Operational Update
04/05/20	PRICE SENSITIVE	147.55KB	Share
GID Additional Information - Appendix 4C
04/05/20	PRICE SENSITIVE	322.82KB	Share
GID Quarterly Activities Report - Q1 2020
01/05/20	PRICE SENSITIVE	133.53KB	Share
GID GID Files Amendment to the Annual Report on SEC Form 10-K
30/04/20	PRICE SENSITIVE	126.54KB	Share
GID Appendix 4C - Quarter Ended 31 March 2020
28/04/20	PRICE SENSITIVE	234.64KB	Share
GID Extension of the Maturity Date of US $5M Convertible Note
01/04/20		136.57KB	Share
GID Appendix 3Z
01/04/20		180.5KB	Share
GID GI Dynamics Announces Change to Board of Directors
30/03/20		126.26KB	Share
GID Appendix 4G - Annual Report
30/03/20		14.01MB	Share
GID Notice of Special Meeting & Engagement of Financial Advisor
23/03/20		8.23MB	Share
GID Appendix 3X
02/03/20		138.15KB	Share
GID Appointment of Director
02/03/20		131.96KB	Share
GID Appendix 4E - Preliminary Final Report
28/02/20	PRICE SENSITIVE	703.91KB	Share
GID Change in substantial holding
03/02/20		232.7KB	Share
GID 1st Patient Enrolled in US STEP-1 EndoBarrier Clinical Trial
28/01/20	PRICE SENSITIVE	132.02KB	Share
GID Change in substantial holding
28/01/20		272.67KB	Share
GID Appendix 4C - Quarter Ended 31 December 2019
24/01/20	PRICE SENSITIVE	312.34KB	Share
GID EndoBarrier Study Shows Improvement in Cardiovascular Risk
15/01/20	PRICE SENSITIVE	270.73KB	Share
GID Confirmation of Funding of 2019 Note, Warrant Issuance & 3B
14/01/20		440.78KB	Share
GID Results of Adjourned Special Meeting
20/12/19		282.61KB	Share
GID Appendix 3Y
19/12/19		205.69KB	Share
GID Appendix 3Y
19/12/19		226.11KB	Share
GID Appendix 3Y
19/12/19		225.72KB	Share
GID Appendix 3Y
19/12/19		205.85KB	Share
GID Appendix 3B Following Stockholder Approvals
17/12/19		648.98KB	Share
GID Results of Special Meeting
17/12/19	PRICE SENSITIVE	231.13KB	Share
GID GID Announces Details of Special Meeting for Stockholders
12/12/19		127.56KB	Share
GID Corporate Presentation
11/12/19		2.17MB	Share
GID Note Funding Update & US Filings
09/12/19		406.73KB	Share
GID Appointment of Auditor
09/12/19		294.74KB	Share
GID GID Announces Extension of Note Funding Date
06/12/19	PRICE SENSITIVE	55.81KB	Share
GID Details of Special Meeting and Confirmation of Note Funding
02/12/19		311.95KB	Share
GID Appointment of an Observer to the Board of Directors
20/11/19		126.31KB	Share
GID Exercise of Tranche 4 Warrants and Appendix 3B
18/11/19		409.4KB	Share
GID Form 10-Q filed with SEC - Q3 2019
11/11/19	PRICE SENSITIVE	654.25KB	Share
GID Change in substantial holding
11/11/19		182.34KB	Share
GID Change in substantial holding
08/11/19		227.37KB	Share
GID Exercise of Tranche 3 Warrants and Appendix 3B
04/11/19		790.28KB	Share
GID Appendix 4C - Quarter Ended 30 September 2019
30/10/19	PRICE SENSITIVE	229.82KB	Share
GID Change in substantial holding
07/10/19		259.5KB	Share
GID Exercise of Tranche 2 Warrants by Crystal Amber and 3B
04/10/19	PRICE SENSITIVE	340.02KB	Share
GID Variation of CEO Employment Terms and Issue of Options
20/09/19	PRICE SENSITIVE	590.6KB	Share
GID Worldwide EndoBarrier Registry Data Presented at EASD 2019
20/09/19		186.84KB	Share
GID Change in substantial holding
05/09/19		295.89KB	Share
GID Change in substantial holding
29/08/19		703.63KB	Share
GID Close of Tranche 1 Warrants Exercise and Appendix 3B
26/08/19		366.49KB	Share
GID Change in substantial holding
26/08/19		274.11KB	Share
GID GID Announces up to Approx.US$10M Financing w/ Crystal Amber
22/08/19	PRICE SENSITIVE	495.11KB	Share
GID Half Yearly Report and Accounts
20/08/19	PRICE SENSITIVE	1MB	Share
GID Surgical Specialists of Louisiana Contracted for STEP-1
31/07/19		113.36KB	Share
GID Appendix 4C - Quarter Ended 30 June 2019
31/07/19	PRICE SENSITIVE	113.33KB	Share
GID GID Confirms Thomas Jefferson Contracted for STEP-1
23/07/19		114.8KB	Share
GID Lead Clinical Study Site for US Pivotal Trial of EndoBarrier
11/07/19	PRICE SENSITIVE	115.89KB	Share
GID Change in substantial holding
08/07/19		260.52KB	Share
GID Conversion of convertible notes by Crystal Amber
02/07/19		330.38KB	Share
GID Issue of Warrants and Conversion of Convertible Notes
01/07/19		363.2KB	Share
GID Results of 2019 Annual Meeting of Stockholders
01/07/19		175.49KB	Share
GID Extension of Maturity Date of US $5M Convertible Note
01/07/19	PRICE SENSITIVE	132.67KB	Share
GID GID Announces Access to 2019 Annual Meeting of Stockholders
25/06/19		135.39KB	Share
GID Final Proxy Statement & Notice of 2019 Annual Meeting
21/06/19		1.08MB	Share
GID 2019 Annual Meeting of Stockholders - Further Update
18/06/19		56.01KB	Share
GID New SAB Member to Focus on Treatment of Liver Disease
18/06/19		116.73KB	Share
GID EndoBarrier End-OSA Shows Significant Improvements Sustained
14/06/19	PRICE SENSITIVE	165.29KB	Share
GID Change in substantial holding
13/06/19		261.87KB	Share
GID GID Confirms First 2 Clinical Study Sites Contracted
13/06/19	PRICE SENSITIVE	117.05KB	Share
GID EndoBarrier Data to be Presented at ADA 2019
06/06/19		142.77KB	Share
GID GI Dynamics 2019 Annual Meeting of Stockholders - Update
04/06/19	PRICE SENSITIVE	72.67KB	Share
GID Q1 2019 Form 10-Q/A
20/05/19	PRICE SENSITIVE	375.92KB	Share
GID Q1 2019 Form 10-Q and 12b-25
17/05/19	PRICE SENSITIVE	1.17MB	Share
GID $3M Convertible Note & Warrant Financing from Crystal Amber
09/05/19	PRICE SENSITIVE	150.41KB	Share
GID Extension of Maturity Date of US $5M Convertible Note
01/05/19	PRICE SENSITIVE	120.53KB	Share
GID Appendix 4C - Quarter Ended 31 March 2019
30/04/19	PRICE SENSITIVE	268.12KB	Share
GID GI Dynamics Announces New Scientific Advisory Board Member
09/04/19		117.14KB	Share
GID EndoBarrier Data to be Presented at 4th WCITD
04/04/19		146.16KB	Share
GID New SAB Member to Advance Focus on Chronic Kidney Disease
02/04/19		115.21KB	Share

REFRESH

1 2 3 4 5

GI DYNAMICS, INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available